Latest market price
10.19
-0.52-4.86%
OverviewShort InterestFilings
XERSQT71Xeris Biopharma Holdings, Inc.·NASDAQ
10.19-4.86%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 30, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 14, 20268-KCurrent report
Oct 02, 20264Statement of changes in beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Sep 29, 20264Statement of changes in beneficial ownership
Sep 09, 20268-KCurrent report
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 20264Statement of changes in beneficial ownership
Aug 21, 20264Statement of changes in beneficial ownership
Aug 21, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Aug 04, 20264Statement of changes in beneficial ownership
Aug 04, 20264Statement of changes in beneficial ownership
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 17, 20268-KCurrent report
Jul 07, 20264Statement of changes in beneficial ownership
Jul 02, 20263Initial statement of beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 30, 20268-KCurrent report
#1 / 25 of 315
Page
▼
/ 13